S3V Vascular Technologies Limited

S3V Vascular Technologies Limited

Medical Equipment/Supplies/Accessories Unlisted Active
INE0HGT01012 Est. 2011 Website
Current Price 24 Aug 2026
₹545.00

Min lot: 500 shares

Market Cap ₹763 Cr
P/E Ratio 10,900.0x
EPS ₹0.05
Face Value ₹13.70
Book Value ₹121.39
P/B Ratio 4.49x
Min Lot 500 sh.
Total Debt ₹18 Cr

Price Trend

Period Change
Period High
Period Low

Prices shown are indicative unlisted-market bid prices, updated periodically.

About S3V Vascular Technologies Limited

A stent costs what it costs largely because somebody imported it. S3V exists to change that arithmetic.

The company was founded in 2011 and works out of Mysuru in Karnataka. It develops, manufactures and sells minimally invasive devices for cardiovascular, neurovascular and critical care work. Drug eluting stents. PTCA balloon catheters. Aspiration catheters and central venous catheters.

R&D happens in house and manufacturing is integrated with it, which for a device company matters more than it sounds, its the difference between designing something and being able to build it at volume.

Neurovascular is where the growth is heading, including mechanical thrombectomy kits used in stroke treatment. Pulling a clot out of a brain artery quickly is one of those procedures where the equipment genuinely decides how the patient ends up.

Investment has come in to scale operations and put up a modern facility. And the ambition does not stop at the Indian market.

Financial Highlights

All figures are in Crores (₹)

FY24FY25 YOY %CAGR %
Net Sales14.913.6-9.2%-9.2%
Other Income0.232.41+947.8%+947.8%
Total Income15.216.0+5.4%+5.4%
Operating Profit-0.991.54+255.6%+55.6%
Interest0.000.00
Depreciation2.071.38-33.3%-33.3%
Total Expenditure18.216.6-8.7%-8.7%
Exceptional Income0.000.00
PBT-3.060.16+105.2%-94.8%
TAX-0.14-0.09+35.7%+35.7%
PAT-3.200.07+102.2%-97.8%
EPS (₹)₹-2.35₹0.05+102.1%-97.9%
FY24FY25 YOY %CAGR %
Shareholder Funds177.6169.9-4.3%-4.3%
Total Debt25.318.3-27.7%-27.7%
Current Liabilities26.223.6-9.9%-9.9%
Non Current Liabilities10.65.50-48.3%-48.3%
Total Liabilities177.6169.9-4.3%-4.3%
Current Assets114.175.0-34.3%-34.3%
Non Current Assets64.095.0+48.3%+48.3%
Total Assets177.6169.9-4.3%-4.3%
FY24FY25 YOY %CAGR %
Cash Flow From Operating Activities-7.33-6.42+12.4%+12.4%
Cash Flow From Investing Activities-30.3-31.1-2.9%-2.9%
Cash Flow From Financing Activities92.6-9.80-110.6%+89.4%
Free Cash Flow-37.6-37.6+0.1%+0.1%
FY24FY25YOY %
ROE(%)-1.800.00+100.0%
ROCE(%)-0.600.90+250.0%
ROA(%)-1.800.00+100.0%
Current Ratio(x)4.303.20-25.6%
Debt / Equity(x)0.140.11-21.4%

No documents available yet.

Net Sales (in Cr.)

Total Income (in Cr.)

Net Profit (in Cr.)

Operating Profit (in Cr.)

Shareholder Funds (in Cr.)

Total Assets (in Cr.)

Operating Cash Flow (in Cr.)

Investing Cash Flow (in Cr.)

Financing Cash Flow (in Cr.)

Free Cash Flow (in Cr.)

Company Information

ISIN INE0HGT01012
Industry Medical Equipment/Supplies/Accessories
Category Pre IPO
Incorporated 2011
Min Lot Size 500 shares
Demat Required Yes
ROFR Applicable No

Frequently Asked Questions

How to buy S3V Vascular Technologies Limited unlisted shares?

You can buy S3V Vascular Technologies Limited unlisted shares through UnlistedGain by clicking the "Buy Shares" button on this page. Our team will guide you through KYC, payment, and direct share transfer to your demat account.

What is the minimum lot size for S3V Vascular Technologies Limited?

The minimum lot size for S3V Vascular Technologies Limited is 500 shares. Transactions are processed in multiples of this quantity.

Is it safe to invest in S3V Vascular Technologies Limited?

Investing in unlisted shares carries risks including illiquidity and limited public disclosures. Through UnlistedGain, shares are transferred directly to your demat account ensuring ownership security. Always consult a SEBI-registered advisor before investing.

What documents are needed to buy S3V Vascular Technologies Limited shares?

You will need a valid Demat account, PAN card, and KYC documents. Our team will guide you through the complete verification process after you submit your inquiry.